-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Monitoring for Adverse Hemostatic Outcomes at the Population Level

Program: Scientific Workshops @ ASH
Session: Prevention and Monitoring
Wednesday, December 2, 2020, 8:35 AM-9:35 AM

Cheryl Maier, MD, PhD

Emory University School of Medicine, Atlanta, GA

Disclosures: No relevant conflicts of interest to declare.